| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 07/06/2005 | CN1634910A Process for preparing epimedium total flavone for injection |
| 07/06/2005 | CN1634909A 3- or 4- carbonyl substituted coumarin connected with naphthenones and its synthesis method and use |
| 07/06/2005 | CN1209357C Tea polyphenols extracting process |
| 07/06/2005 | CN1209342C Process of preparing tolterodine and analogues thereof as well as intermediates prepared in the process |
| 07/05/2005 | US6914072 E.g., ajulemic acid; used for decreasing cell proliferation |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 07/05/2005 | CA2129813C 5-aminoflavone derivatives |
| 06/30/2005 | WO2005058798A2 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same |
| 06/30/2005 | WO2005040357A3 Compounds and methods for fluorescent labeling |
| 06/30/2005 | WO2004089926A3 Genipin derivatives and uses thereof |
| 06/30/2005 | US20050143588 synthesis of phytoestrogenic isoflavone metabolites and derivatives from the hydrogenation products of isoflavones; hydrogenation of isoflavones to relatively pure tetrahydroisoflavan-4-ol products in excellent yields, and without need for pharmaceutically unsuitable solvents and extensive chromatography |
| 06/30/2005 | US20050143449 Non-steroidal farnesoid X receptor modulators and methods for the use thereof |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | DE10357004A1 Flavonoid-Derivat Flavonoid derivative |
| 06/30/2005 | CA2550123A1 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same |
| 06/29/2005 | EP1546391A2 Energy transfer dyes, terminators and use thereof |
| 06/29/2005 | EP1546359A2 Site-specific labeling of affinity tags in fusion proteins |
| 06/29/2005 | EP1546125A2 Fluorescent labeling reagents with multiple donors and acceptors |
| 06/29/2005 | EP1546086A2 Aminoalcohol derivatives |
| 06/29/2005 | EP1545507A2 Activated checkpoint therapy and methods of use thereof |
| 06/29/2005 | EP1545502A2 Keto cannabinoids with therapeutic indications |
| 06/29/2005 | EP1545501A2 Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
| 06/29/2005 | EP1545206A2 Compositions and products containing enantiomeric equol, and methods for their making |
| 06/29/2005 | CN1633427A Method for preparing chiral amines |
| 06/29/2005 | CN1631879A Substituted phenyl keto enols as pesticides and herbicides |
| 06/29/2005 | CN1631274A Extrusion processing method and device for extracting soybean isoflavone, saponin and oligosaccharide |
| 06/29/2005 | CN1208332C Process for extracting natural tocopherol |
| 06/28/2005 | US6911547 Such as 4-methylene-3-oxabicyclo(3.2.1)octan-2-one; herbicides/chemical intermediates |
| 06/28/2005 | US6911457 Diabetes imaging probes |
| 06/23/2005 | WO2005056544A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders |
| 06/23/2005 | WO2005056510A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/23/2005 | WO2005056508A1 Method for the production of tetrahydrogeranylacetone |
| 06/23/2005 | WO2005037817A3 Method for producing chromane derivatives that are devoid of enantiomers and are substituted in position 2 |
| 06/23/2005 | WO2005032485A3 Compounds and methods for the treatment of attention-deficit hyperactivity disorder |
| 06/23/2005 | WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 06/23/2005 | WO2004024081A3 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 06/23/2005 | US20050137252 Production of dihydronepetalactone |
| 06/23/2005 | US20050137231 Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| 06/23/2005 | US20050137228 Benzyl sulfonamide derivatives |
| 06/23/2005 | US20050137191 Nitrate esters and their use for mitigating cellular damage |
| 06/23/2005 | US20050136503 Fluorescent pH indicators for intracellular assays |
| 06/23/2005 | US20050136288 Efficiency, durability, amine hole transporting material |
| 06/23/2005 | CA2548922A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders |
| 06/23/2005 | CA2548262A1 Method for the production of tetrahydrogeranylacetone |
| 06/23/2005 | CA2545112A1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/22/2005 | EP1542984A2 Methods of purifying cannabinoids from plant material |
| 06/22/2005 | EP1542983A1 Heterodiamondoids |
| 06/22/2005 | EP1542975A2 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides |
| 06/22/2005 | EP1542675A1 Compounds useful for the inhibition of aldh |
| 06/22/2005 | EP1373243B1 Aminoflavone compounds, compositions, and use thereof |
| 06/22/2005 | EP1339704B1 Method for continuously acylating chromanol ester derivatives |
| 06/22/2005 | EP1265885B1 Hydroxylated/carboxylated naphthopyrans |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | CN1630632A Aromatic amino acid derivates and medicinal compositions |
| 06/22/2005 | CN1630555A Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 06/22/2005 | CN1629154A Method for synthesizing optical enantiomer 6-fluoro-3, 4-dihydro-2H-1-benzopyran-2-carboxylic acid and 6-fluoro-3, 4-dihydro-2H-1-benzopyran-2-carboxylate |
| 06/22/2005 | CN1207293C 11-carboxypropyl substituted benzo-(a)Xanthone compound and photochemical synthesizing method |
| 06/22/2005 | CN1207292C Synthetic methods for preparing procyanidin ligomers |
| 06/21/2005 | US6908943 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/21/2005 | US6908942 Carbocyclic oxy amines such as 2,2-dimethyl-3-(4-fluorobenzyl) ether-4-methoxy-6-(4-methoxybenzyl)amino Benzopyran and libraries, used for prophylaxis of eating disorders induced by lipid peroxidation; antioxidants |
| 06/21/2005 | US6908927 Reduction physical cigarette smoking |
| 06/21/2005 | US6908917 Chromone derivatives as matrix metalloproteinase inhibitors |
| 06/21/2005 | CA2108068C Carbamates of rapamycin |
| 06/16/2005 | WO2005054809A2 Irciniastatins a and b |
| 06/16/2005 | WO2005054224A2 Derivatives of dihydronepetalactone and method for preparation |
| 06/16/2005 | WO2005054223A2 Process for the manufacture of alkenylated hydroxylated aromatic compounds, of chroman compounds and of their acylated derivatives |
| 06/16/2005 | WO2005054222A2 Flavonoid derivative |
| 06/16/2005 | WO2005053678A1 Therapeutic or preventive agents for ischemic neuropathy |
| 06/16/2005 | WO2005053676A1 Use of pentadienoic acid derivatives for the treatment of hyperuricemia |
| 06/16/2005 | WO2005053415A1 Package drink |
| 06/16/2005 | WO2005032559A8 Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
| 06/16/2005 | US20050131240 Process for separating tocopherol homologues |
| 06/16/2005 | US20050131226 Rearranged pentanols, a process for their production and their use as anti-inflammatory agents |
| 06/16/2005 | US20050130221 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 06/16/2005 | CA2547543A1 Use of pentadienoic acid derivatives for the treatment of hyperuricemia |
| 06/16/2005 | CA2546820A1 Derivatives of dihydronepetalactone and method for preparation |
| 06/15/2005 | EP1539728A2 Fluorescent dyes, energy transfer couples and methods |
| 06/15/2005 | EP1539150A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 06/15/2005 | EP1539137A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 06/15/2005 | EP1419163B1 Tricyclic imidazopyridines |
| 06/15/2005 | CN1626534A Steroid receptor modulator compounds and methods |
| 06/15/2005 | CN1206227C Method for picking-up general flavone from hawthorn fruit by using microwave |
| 06/14/2005 | US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran |
| 06/14/2005 | US6906007 Insecticides, miticides |
| 06/14/2005 | US6905786 A thin layer contains aromatic tert-amine compound, sandwiched between a pair of electrodes; brightness |
| 06/09/2005 | WO2005051955A1 Novel compound and medicinal composition |
| 06/09/2005 | WO2005051844A2 Processes for preparing salts of alcohol polybasic acid partial esters using metal oxides, metal hydroxides and/or metal carbonates |
| 06/09/2005 | WO2005026142A3 Synthesis of alpha-tocopheryl alkanoates and precursors thereof |
| 06/09/2005 | WO2005025500A3 Process for preparing water soluble diterpenes and their applications |
| 06/09/2005 | US20050124826 Processes for preparing salts of alcohol polybasic acid partial esters using metal oxides, metal hydroxides and/or metal carbonates |
| 06/09/2005 | US20050124688 Process for synthesizing d-tocotrienols from 2-vinylchromane compound |
| 06/09/2005 | US20050124687 Process for synthesizing d-tocotrienols |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/09/2005 | US20050123633 Obtained by fermenting soybean germ, which is used as raw material, with koji mold, thus breaking down proteins, then hydrolyzing, extracting and concentrating using solvent to produce an isoflavone aglycone concentrate |
| 06/09/2005 | US20050123478 Agent for measurement of singlet oxygen |
| 06/08/2005 | EP1537124A1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 06/08/2005 | EP1537090A1 Chromone derivatives as matrix metalloproteinase inhibitors |
| 06/08/2005 | EP1537068A1 Materials and methods for treating hypercholesterolemia |